From the *Department of Public Health, Weill Medical College of Cornell University, New York, New York; †Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; ‡Department of Medicine and the Partners AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; §Departments of Biostatistics and Epidemiology, Boston University School of Public Health, Boston, Massachusetts; ¶Departments of Health Policy and Management and of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; and ∥Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts.
Supported in part by the National Institute of Allergy and Infectious Diseases (K23 AI01794, K24 AI062476, K25 AI50436, P30 AI42851 and R01 AI42006), the National Institute on Drug Abuse (K01 DA17179 and K23 DA00523), and the Agency for Healthcare Research and Quality (Contract 290-01-0012).
Presented in part at the 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment, July 24–27, 2005, Rio de Janeiro, Brazil.
Reprints: Bruce R. Schackman, PhD, Assistant Professor of Public Health, Department of Public Health, Weill Medical College of Cornell University, 411 East 69th Street, New York, NY 10021. E-mail: [email protected].
